Skip to main content
. 2008 May 27;98(12):1959–1965. doi: 10.1038/sj.bjc.6604387

Table 2. Platinum pharmacokinetic parameters during the first cycle (Mean±s.d.; n=37).

  Cmax (μg ml−1) AUC (μg·h ml−1) t1/2λ1 (h) t1/2z (h) CL (L h−1) Vss (L)
Ultrafiltrate 6.69±12.5 9.45±5.11 0.22±0.08 18.7±5.2 14.8±5.02 255±92
Plasma 9.32±13.5 108±25 0.45±0.46 33.7±6.7 1.19±0.40 54.9±18.7
HHS Vulnerability Disclosure